Research Group receive Innovate UK ICURe SETsquared Award
We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape.
Our Research Associate Simon Porter is currently undertaking these activities remotely via conference attendance and engagement.
Further information on the programme can be found at the link below:
Our EPSRC research selected as case study
Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]
Advanced Science News Coverage and Advanced Healthcare Materials paper
Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials
Our peptide hydrogel research wins Controlled Release Society’s 2020 People’s Choice Award
We are excited to hear our research on the use of peptide hydrogels for HIV/AIDs drug delivery won the overall CRS People’s Choice Award at the recent CRS virtual meeting. The presentation, as well as our other work, is available to conference participants by clicking the relevant title below. Poster: Poster number 63. Peptide-like […]